127.full januar

More patients with opioid addiction are receiving opioid agonist
therapy (OAT) with methadone and buprenorphine. As a result,
physicians will more frequently encounter patients receiving OAT
who develop acutely painful conditions, requiring effective treatment
strategies. Undertreatment of acute pain is suboptimal medical
treatment, and patients receiving long-term OAT are at particular
risk. This paper acknowledges the complex interplay among
addictive disease, OAT, and acute pain management and describes
4 common misconceptions resulting in suboptimal treatment of
acute pain. Clinical recommendations for providing analgesia for
patients with acute pain who are receiving OAT are presented.
Although challenging, acute pain in patients receiving this type of
therapy can effectively be managed.